- Home
- BMY vs SBUX Comparison
BMY vs SBUX Comparison
Compare BMY & SBUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMY | SBUX |
|---|---|---|
| Founded | 1887 | 1971 |
| Country | United States | United States |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.5B | 120.0B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | BMY | SBUX |
|---|---|---|
| Price | $55.53 | $101.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 29 |
| Target Price | $61.73 | ★ $104.39 |
| AVG Volume (30 Days) | ★ 11.7M | 7.7M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 4.38% | 2.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | N/A | ★ $37,184,400,000.00 |
| Revenue This Year | N/A | $4.88 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | ★ $17.26 | $143.07 |
| Revenue Growth | N/A | ★ 2.79 |
| 52 Week Low | $42.52 | $77.99 |
| 52 Week High | $62.89 | $108.88 |
Technical Indicators
Market Signals| Indicator | BMY | SBUX |
|---|---|---|
| Relative Strength Index (RSI) | 47.65 | 51.93 |
| Support Level | $53.98 | $93.59 |
| Resistance Level | $57.43 | $101.68 |
| Average True Range (ATR) | 1.21 | 2.56 |
| MACD | -0.09 | 0.32 |
| Stochastic Oscillator | 53.94 | 72.74 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About SBUX Starbucks Corporation
Starbucks stands out as the world's biggest and most recognizable coffee brand, powered by ultracustomizable beverages in-store and a sweeping footprint of nearly 41,000 cafes in over 80 countries. About 52% are company-operated, with the balance run by licensees. The company operates roasteries and sells across its North America (74% of revenue as of the end of fiscal 2025), international (21%), and channel development (5%) segments. The brand collects revenue from company-operated stores, licensee royalties, equipment and product sales, retail ready-to-drink beverages, and packaged coffee.